KAPLAN, H. Et Al. 2024. Examining the Seroprevalance and Antiviral Prophylaxis Rate of Hepatitis B and C Virus in Rheumatic Patients Treated with Biological and Targeted Synthetic Disease Modifying Anti-rheumatic Drugs: Results from a Tertiary Center in Central Anatolia. Genel Tıp Dergisi , vol.34, no.1 , 88-93.

KAPLAN, H., CENGİZ, G., ŞAŞ, S., & KARA, H., (2024). Examining the Seroprevalance and Antiviral Prophylaxis Rate of Hepatitis B and C Virus in Rheumatic Patients Treated with Biological and Targeted Synthetic Disease Modifying Anti-rheumatic Drugs: Results from a Tertiary Center in Central Anatolia. Genel Tıp Dergisi , vol.34, no.1, 88-93.

KAPLAN, HÜSEYİN Et Al. "Examining the Seroprevalance and Antiviral Prophylaxis Rate of Hepatitis B and C Virus in Rheumatic Patients Treated with Biological and Targeted Synthetic Disease Modifying Anti-rheumatic Drugs: Results from a Tertiary Center in Central Anatolia," Genel Tıp Dergisi , vol.34, no.1, 88-93, 2024

KAPLAN, HÜSEYİN Et Al. "Examining the Seroprevalance and Antiviral Prophylaxis Rate of Hepatitis B and C Virus in Rheumatic Patients Treated with Biological and Targeted Synthetic Disease Modifying Anti-rheumatic Drugs: Results from a Tertiary Center in Central Anatolia." Genel Tıp Dergisi , vol.34, no.1, pp.88-93, 2024

KAPLAN, H. Et Al. (2024) . "Examining the Seroprevalance and Antiviral Prophylaxis Rate of Hepatitis B and C Virus in Rheumatic Patients Treated with Biological and Targeted Synthetic Disease Modifying Anti-rheumatic Drugs: Results from a Tertiary Center in Central Anatolia." Genel Tıp Dergisi , vol.34, no.1, pp.88-93.

@article{article, author={HÜSEYİN KAPLAN Et Al. }, title={Examining the Seroprevalance and Antiviral Prophylaxis Rate of Hepatitis B and C Virus in Rheumatic Patients Treated with Biological and Targeted Synthetic Disease Modifying Anti-rheumatic Drugs: Results from a Tertiary Center in Central Anatolia}, journal={Genel Tıp Dergisi}, year=2024, pages={88-93} }